Skip to content

Allen & Overy advises Biogroup on two high-yield bond issues and a new senior facilities agreement

Related people
David Jean-Christophe
Jean-Christophe David

Partner

Paris

View profile →

Geraldine Lezmi

Senior Associate

Paris

View profile →

Repiquet Adrien
Adrien Repiquet

Associate

Paris

View profile →

Reda Boujnini

Associate

Paris

View profile →

Press contacts

For media enquiries relating to this topic, please contact:

Amina Elothmani

Communications Officer

Paris

View profile →

12 February 2021

PARIS – Biogroup, the leading private medical laboratory services group in France and Belgium, has successfully completed through its two main subsidiaries the issuance of EUR800million in aggregate principal amount of senior secured notes due 2028 with a fixed interest rate of 3.375% and the issuance of EUR250m in aggregate principal amount of senior secured notes due 2029 with a fixed interest rate of 5%.

In parallel to these issuances, Biogroup has entered into a new senior facilities agreement in an aggregate principal amount of EUR1.721billion
Raising nearly EUR2.771b has enabled Biogroup to refinance its existing debt and optimize its financing structure.

The Allen & Overy team was led in Paris by Banking partner Jean-Christophe David and senior associate Geraldine Lezmi, assisted by associates Adrien Repiquet and Reda Boujnini.